This is the limited version of the EyeGate Pharmaceuticals company profile: Join LinkedIn or Sign In to see more information.
Eyegate Pharmaceuticals, Inc. engages in developing transscleral iontophoresis drug-delivery platform for the treatment of eye disorders. Its product includes EyeGate II Delivery System, which can be used for the ocular application of various drugs and for the treatment of eye disorders, such as uveitis, choroidal neovascularization, cancer, and glaucoma. The company was founded in 1998 and is headquartered in Paris, France.
Your Connections to EyeGate Pharmaceuticals
Popular Profiles at EyeGate Pharmaceuticals
Tour de l’Horloge
4, place Louis Armand
Paris
75012
United States
Phone: 33 1 47 57 43 23
Fax: 33 1 40 89 09 22
Estimated based on LinkedIn Data
Career path for EyeGate Pharmaceuticals employees
In partnership with 
Send feedback on BusinessWeek/CapIQ content to linkedinissues@capitaliq.com. Copyright © 2009 Capital IQ.
This LinkedIn Company Profile was created by LinkedIn and is about EyeGate Pharmaceuticals. This page is not endorsed by or affiliated with EyeGate Pharmaceuticals. For questions regarding LinkedIn Company Profiles, contact us.
| 